Industry Trend

Site Sections


Menu













© 2023. All Rights reserved.

Overview for CHUGAI PHARMACEUTICAL

All Data per March 2, 2023

Industry:

Drug Manufacturers—General

Last Close:

3,396.00 JPY

Expected Dividend:

0.00 %

Payoffs per Year:

2.0
Business Summary

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.


Competitors View

Ordering

ABBVIE

USA
1.03 4.28%
3.61%
7.39% 5.46% 1.0 4.36
-9.47%
43.02 13.08% 10.52 1.0

CHUGAI PHARMACEUTICAL

JPN
0.96 2.56%
0.0%
22.5% 6.68% 1.0 4.24
-32.13%
32.9 15.38% 77.21 2.0

PFIZER

USA
0.95 3.64%
3.96%
2.76% 3.76% 1.0 3.02
-11.11%
49.05 9.25% 42.54 3.0

ASTRAZENECA

GBR
1.04 4.07%
2.74%
1.15% 3.92% 1.0 11.56
-3.86%
98.3 11.66% 37.27 4.0

DAIICHI SANKYO

JPN
1.05 4.24%
0.0%
0.0% 3.88% 1.0 8.15
-17.26%
35.15 18.52% 61.0 5.0

SANOFI

FRA
1.01 3.78%
4.03%
0.74% 3.58% 1.0 0.57
-12.18%
51.83 7.75% 57.12 6.0

BRISTOL-MYERS SQUIBB

USA
0.98 2.8%
3.1%
1.83% 2.78% 1.0 0.5
-24.44%
34.92 17.8% 32.88 7.0

MERCK & CO.

USA
1.12 3.12%
2.64%
2.24% 3.15% 1.0 2.31
-11.68%
55.47 10.37% 36.13 8.0

KYOWA HAKKO KOGYO

JPN
0.96 1.88%
1.67%
7.74% 2.44% 1.0 3.6
-15.61%
35.6 3.07% 79.96 9.0

GILEAD SCIENCES

USA
1.16 2.74%
3.6%
5.91% 3.26% 1.0 0.15
-42.43%
33.49 -1.11% 31.01 10.0

ELI LILLY AND COMPANY

USA
1.04 2.43%
1.22%
2.86% 2.52% 1.0 7.52
-12.71%
42.91 5.87% 18.4 11.0

ROCHE

CHE
0.92 3.28%
3.51%
0.79% 3.11% 1.0 1.4
-15.85%
37.23 2.14% 26.53 12.0

AMGEN

USA
1.0 2.42%
3.28%
8.46% 3.24% 1.0 3.5
-9.93%
35.72 -5.0% 10.95 13.0

GLAXOSMITHKLINE

GBR
0.96 5.37%
5.27%
0.35% 5.0% -0.5 0.21
-24.56%
49.96 2.63% 19.03 14.0

ASTELLAS PHARMA

JPN
0.96 2.43%
0.0%
1.74% 2.4% 1.0 1.09
-19.06%
27.18 -1.76% 60.96 15.0

OTSUKA HOLDINGS CO., LTD.

JPN
0.93 2.21%
2.54%
0.0% 2.02% 1.0 -0.41
-14.62%
28.52 12.2% 71.29 16.0

BAYER

GER
1.02 2.51%
3.99%
4.7% 2.83% 0.5 -0.36
-58.76%
36.97 -17.89% 27.46 17.0

JOHNSON & JOHNSON

USA
0.98 2.68%
0.0%
0.0% 2.46% 1.0 -1.0
13.03%
44.08 2.58% 40.67 18.0

GRIFOLS SA

ESP
0.98 1.5%
nan%
4.84% 1.7% -0.5 0.24
-46.29%
31.86 -1.95% 31.7 nan


Information for CHUGAI PHARMACEUTICAL

Yield Triangle

Dividend & Close

Close Dividend Return (%)
Year
2012 550.33 40.00 7.27
2013 775.00 45.00 5.81
2014 988.00 45.00 4.55
2015 1,413.33 10.67 0.75
2016 1,118.33 17.33 1.55
2017 1,923.33 20.67 1.07
2018 2,126.67 15.00 0.71
2019 3,360.00 30.67 0.91
2020 5,503.00 125.00 2.27
2021 3,735.00 60.00 1.61
2023 3,396.00 0.00 0.00

Fundamentals

Chart